260 related articles for article (PubMed ID: 10741147)
41. Monoclonal antibodies in advanced B-cell lymphomas.
Ujjani C; Cheson BD
Oncology (Williston Park); 2010 Feb; 24(2):156-66. PubMed ID: 20361466
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis and management of lymphoma.
Abbott BL
Clin Lymphoma Myeloma; 2006 Jul; 7(1):30-2. PubMed ID: 16879767
[TBL] [Abstract][Full Text] [Related]
43. Clearing minimal residual disease with rituximab consolidation therapy.
Brugger W
Semin Oncol; 2004 Feb; 31(1 Suppl 2):33-7. PubMed ID: 15042533
[TBL] [Abstract][Full Text] [Related]
44. High-dose therapy for indolent lymphoma.
Mounier N; Socié G; Gisselbrecht C
Crit Rev Oncol Hematol; 2002 Feb; 41(2):225-39. PubMed ID: 11856598
[TBL] [Abstract][Full Text] [Related]
45. Current therapeutic strategies and new treatment paradigms for follicular lymphoma.
Kritharis A; Sharma J; Evens AM
Cancer Treat Res; 2015; 165():197-226. PubMed ID: 25655611
[TBL] [Abstract][Full Text] [Related]
46. [Current treatment strategy in mantle cell lymphoma].
Ogura M
Nihon Rinsho; 2014 Mar; 72(3):499-511. PubMed ID: 24724411
[TBL] [Abstract][Full Text] [Related]
47. Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems.
Meusers P; Hense J; Brittinger G
Leukemia; 1997 Apr; 11 Suppl 2():S60-4. PubMed ID: 9178843
[TBL] [Abstract][Full Text] [Related]
48. Monoclonal antibody therapy for B-cell malignancies.
Cheson BD
Semin Oncol; 2006 Apr; 33(2 Suppl 5):S2-14. PubMed ID: 16720198
[TBL] [Abstract][Full Text] [Related]
49. Radioimmunotherapy with 177Lu-DOTA-rituximab: final results of a phase I/II Study in 31 patients with relapsing follicular, mantle cell, and other indolent B-cell lymphomas.
Forrer F; Oechslin-Oberholzer C; Campana B; Herrmann R; Maecke HR; Mueller-Brand J; Lohri A
J Nucl Med; 2013 Jul; 54(7):1045-52. PubMed ID: 23572496
[TBL] [Abstract][Full Text] [Related]
50. Considerations with newer regimens for indolent non-Hodgkin lymphoma.
Rummel M
Clin Lymphoma Myeloma; 2008 Aug; 8 Suppl 4():S128-36. PubMed ID: 18952543
[TBL] [Abstract][Full Text] [Related]
51. Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma.
Gopal AK; Gooley TA; Rajendran JG; Pagel JM; Fisher DR; Maloney DG; Appelbaum FR; Cassaday RD; Shields A; Press OW
Biol Blood Marrow Transplant; 2014 Jun; 20(6):770-5. PubMed ID: 24530971
[TBL] [Abstract][Full Text] [Related]
52. Are we nearing an era of chemotherapy-free management of indolent lymphoma?
Bachy E; Salles G
Clin Cancer Res; 2014 Oct; 20(20):5226-39. PubMed ID: 25320372
[TBL] [Abstract][Full Text] [Related]
53. Should there be a standard therapy for mantle cell lymphoma?
Smith MR
Future Oncol; 2011 Feb; 7(2):227-37. PubMed ID: 21345142
[TBL] [Abstract][Full Text] [Related]
54. Current treatment standards and emerging strategies in mantle cell lymphoma.
Dreyling M; Hiddemann W;
Hematology Am Soc Hematol Educ Program; 2009; ():542-51. PubMed ID: 20008239
[TBL] [Abstract][Full Text] [Related]
55. [Therapy of follicular lymphoma].
Buske C; Unterhalt M; Hiddeman W
Internist (Berl); 2007 Apr; 48(4):372-81. PubMed ID: 17287964
[TBL] [Abstract][Full Text] [Related]
56. Radioimmunotherapy for treatment of B-cell lymphomas and other hematologic malignancies.
Park SI; Press OW
Curr Opin Hematol; 2007 Nov; 14(6):632-8. PubMed ID: 17898567
[TBL] [Abstract][Full Text] [Related]
57. Rituximab for indolent lymphomas before and after allogeneic hematopoietic stem cell transplantation.
Cieri N; Di Bartolo O; Corradini P
Curr Opin Hematol; 2015 Nov; 22(6):469-75. PubMed ID: 26390162
[TBL] [Abstract][Full Text] [Related]
58. In vitro and in vivo purging of B lymphoma cells from stem-cell products using anti-CD20 Abs.
Derigs HG
Cytotherapy; 2000; 2(6):445-53. PubMed ID: 12044225
[TBL] [Abstract][Full Text] [Related]
59. Follicular lymphoma: today's treatments and tomorrow's targets.
Aurora V; Winter JN
Expert Opin Pharmacother; 2006 Jul; 7(10):1273-90. PubMed ID: 16805715
[TBL] [Abstract][Full Text] [Related]
60. Unmet needs in the treatment of mantle cell lymphoma.
Rosen ST; Link BK; Fowler NH
Clin Adv Hematol Oncol; 2013 Nov; 11(11 Suppl 18):1-19. PubMed ID: 24893041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
